Skip to main content

Table 3 The association between these SNPs and TC risk

From: Variants in TPO rs2048722, PTCSC2 rs925489 and SEMA4G rs4919510 affect thyroid carcinoma susceptibility risk

SNP

Model

Genotype

Cases

Controls

OR (95%CI)

P

rs2048722

Co-dominant

G/G

99 (27.2%)

143 (29.7%)

1.00

 

TPO

 

G/A

174 (47.8%)

233 (48.4%)

1.08(0.78–1.49)

0.636

  

A/A

91 (25.0%)

105 (21.8%)

1.25(0.85–1.83)

0.254

 

Dominant

G/G

99 (27.2%)

143 (29.7%)

1.00

 
  

G/A-A/A

265 (72.8%)

338 (70.3%)

1.13(0.84–1.53)

0.418

 

Recessive

G/G-G/A

273 (75.0%)

376 (78.2%)

1.00

 
  

A/A

91 (25.0%)

105 (21.8%)

1.19(0.86–1.64)

0.294

 

Additive

1.12(0.92–1.35)

0.260

rs925489

Co-dominant

T/T

280 (76.7%)

418 (83.9%)

1.00

 

PTCSC2

 

T/C

83 (22.7%)

78 (15.7%)

1.59(1.12–2.24)

0.009**

  

C/C

2 (0.60%)

2 (0.40%)

1.43(0.20–10.27)

0.721

 

Dominant

T/T

280 (76.7%)

418 (83.9%)

1.00

 
  

T/C-C/C

85 (23.3%)

80 (16.1%)

1.58(1.12–2.23)

0.009**

 

Recessive

T/T-T/C

363 (99.5%)

496 (99.6%)

1.00

 
  

C/C

2 (0.60%)

2 (0.40%)

1.31(0.18–9.41)

0.786

 

Additive

 

1.54(1.10–2.15)

0.010*

rs4919510

Co-dominant

G/G

118 (32.3%)

135 (27.3%)

1.00

 

SEMA4G

 

G/C

168 (46.0%)

257 (51.9%)

0.74(0.54–1.02)

0.064

  

C/C

79 (21.6%)

103 (20.8%)

0.88(0.60–1.29)

0.506

 

Dominant

G/G

118 (32.3%)

135 (27.3%)

1.00

 
  

G/C-C/C

247 (67.7%)

360 (72.7%)

0.78(0.58–1.05)

0.102

 

Recessive

G/G-G/C

286 (78.4%)

392 (79.2%)

1.00

 
  

C/C

79 (21.6%)

103 (20.8%)

1.06(0.76–1.47)

0.786

 

Additive

0.92(0.76–1.11)

0.385

  1. CI, confidence interval; OR, odds ratio; SNP: single nucleotide polymorphism
  2. Bold type *p < 0.05 indicates statistical significance